Sound waves target brain cancer in new trial
NCT ID NCT06665724
Summary
This early-stage study tested the safety of a new two-part therapy for aggressive brain tumors. Before standard surgery, patients received a drug that makes tumor cells sensitive to light, followed by focused ultrasound waves aimed at activating the drug to damage the cancer. The goal was to see if this approach is safe and might help shrink tumors before the main treatment begins.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Neurosurgery, University Hospital Münster
Münster, 48149, Germany
Conditions
Explore the condition pages connected to this study.